Risks with Cytoreductive TherapyVideo Categories: Polycythemia Vera
Supported through funding from Incyte
Dr. Stainthorpe explains that when it comes to bringing personalized medicines to fruition, the challenge is the same worldwide. It is an effort that requires better understanding of disease pathways and markers as well as improved diagnostics.
Linda Bosserman provides insight into positive data around payer-provider collaborations